Accuri C6 Flow Cytometer System
A more recent version of this article appeared on December 1, 2007 Originally published online as doi:10.1189/jlb.0507272 on September 7, 2007

Published online before print August 28, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0507272v1
jlb.0507272v2
82/6/1491    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eriksson, J.
Right arrow Articles by Venge, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eriksson, J.
Right arrow Articles by Venge, P.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0507272


Received for publication May 3, 2007.
Revised July 12, 2007.
Accepted for publication July 17, 2007.


Article

A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein

Jenny Eriksson *@, Charlotte Woschnagg *, Eva Fernvik {dagger}, and Per Venge *

*Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden; and {dagger}Bio-Rad Laboratories, Sundbyberg, Sweden

@ To whom correspondence should be addressed. E-mail: jenny.eriksson{at}medsci.uu.se.


arrow
Abstract

Eosinophil cationic protein (ECP), a secretory protein of the eosinophil granulocyte, is a basic and highly heterogeneous protein. This heterogeneity is dependent on polymorphisms in the ECP gene and post-translational modifications, and it affects the functional properties of the protein in terms of cytotoxicity. The aim of this study was to further investigate the molecular heterogeneity, hence, an affinity capture assay based on an antigen-antibody interaction with the surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) technique was developed. Of three monoclonal antibodies tested, that is, EG2, 614, and 652, the 614 mab was chosen for the experiments. ECP heterogeneity of single individuals was studied in extracts of purified blood eosinophils, and the presence of ~5 major molecular species was demonstrated in each subject. ECP from subjects with different ECP 434(G>C) genotypes (arg97thr) showed mass differences corresponding to the amino acid shift from arginine to threonine. ECP purified from pooled leukocytes of large numbers of healthy blood donors demonstrated an extensive mass heterogeneity with ~10 major molecular species. By the use of a variety of glucosidases it was shown that this heterogeneity was mainly due to N-linked oligosaccharides on which sialic acid, galactose, and acetylglucosamine was positioned. We conclude that the SELDI-TOF MS technique using specific monoclonal antibodies is a convenient and versatile tool; by means of this technique, we could detect both genetic and post-translational causes of the molecular heterogeneity of the eosinophil cationic protein.

Key Words: eosinophil granulocyte • proteomics • glycosylation • gene polymorphism




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Woschnagg, J. Rubin, and P. Venge
Eosinophil Cationic Protein (ECP) Is Processed during Secretion
J. Immunol., September 15, 2009; 183(6): 3949 - 3954.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Plager, M. D. P. Davis, A. G. Andrews, M. J. Coenen, T. J. George, G. J. Gleich, and K. M. Leiferman
Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity
J. Immunol., September 15, 2009; 183(6): 4013 - 4020.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Rubin, U. Zagai, K. Blom, A. Trulson, A. Engstrom, and P. Venge
The Coding ECP 434(G>C) Gene Polymorphism Determines the Cytotoxicity of ECP but Has Minor Effects on Fibroblast-Mediated Gel Contraction and No Effect on RNase Activity
J. Immunol., July 1, 2009; 183(1): 445 - 451.
[Abstract] [Full Text] [PDF]